Cidara Therapeutics (CDTX.US): The 2024 Q1 financial report achieved revenue of US$8.463 million, with a previous value of US$25.99 million, with an expected value of US$9.03 million; earnings per share was -2.28 USD, previous value of USD 0.60, and expected value of -0.80 USD.
Cidara Therapeutics(CDTX.US)：2024年Q1财报实现营收846.3万美元，前值为2599万美元，预期值为903万美元；每股收益为-2.28美元，前值为0.60美元，预期值为-0.80美元。
Cidara Therapeutics (CDTX.US): The 2024 Q1 financial report achieved revenue of US$8.463 million, with a previous value of US$25.99 million, with an expected value of US$9.03 million; earnings per share was -2.28 USD, previous value of USD 0.60, and expec
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated